中國智能集團(00395.HK)擬聯手華康生物醫學(08622.HK)設立香港合資公司
格隆匯4月2日丨中國智能集團(00395.HK)及華康生物醫學(08622.HK)聯合宣佈,於2020年4月2日,Forever Triumph與Nutronic Biomedical(各自分別為智能及華康的直接全資附屬公司)訂立諒解備忘錄,內容有關可能於香港成立一間合資公司,以設立及經營及╱或授權第三方設立及經營跨境電子商務平台,以供於中國大陸及香港銷售、營銷及分銷產品系列及訂約方可能不時協定的其他新產品;及於中國大陸及香港透過其他渠道銷售、營銷及推廣產品系列。
合資公司的建議已發行股本為10萬港元,將由Forever Triumph及Nutronic Biomedical分別持有51%及49%權益。預計所有必要的註冊及營運資金將由訂約方根據彼等各自於合資公司的股權出資。
Nutronic Biomedical擬將向合資公司授出或以其他方式授予在中國及香港銷售、營銷及分銷產品系列之獨家權利,而Forever Triumph擬將利用其在中國及香港之分銷平台及渠道管理產品系列之銷售及營銷。因此,預期各訂約方的資源彙集後將產生寶貴的協同效應,而智能董事會及華康董事會各自認為,諒解備忘錄項下擬進行的合作將有利及符合智能、華康及其各自股東的利益。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.